Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong A.P. Pharma?

A.P. Pharma

Chief Commercial Officer

Northwest Biotherapeutics Inc

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Northwest Biotherapeutics Inc

Company Description

Northwest was concurrently developing a second product, DCVax-L, a dendritic cell vaccine for glioblastoma multiforme or GBM. In 2004, Northwest began a collaboration with investigators at UCLA who conducted two phase I trials for DCVax-L. The trials evaluated... more.

Find other employees at this company (46)

Background Information

Employment History

Global Head Of Oncology

Bayer HealthCare AG


President

PreScience Labs LLC


Vice President Clinical Development, Actelion Pharmaceuticals, Senior Vice President Medical

J. Robert Scott


Vice President of Clinical Development, Vice President of Clinical Development

Financial News


Corporate Controller of The Cooper Companies, Vice President, Finance and Administration

CooperVision Inc


Affiliations

CCBN.com Inc

Board Member


Heron Therapeutics Inc

Board Member


A.P. Pharma Inc

Chief Commercial Officer


Prescription Drug User Fee Act

Founder


Web References(200 Total References)


A.P. Pharma: Management Change is a Positive for the Stock (APPA.OB, $0.39) | Expert Financial Analysis and Reporting | Smith on Stocks

smithonstocks.com [cached]

A.P. Pharma: Management Change is a Positive for the Stock (APPA.OB, $0.39) | Read more… | See my recent blog
A.P. Pharma: Management Change is a Positive for the Stock (APPA.OB, $0.39) | Expert Financial Analysis and Reporting | Smith on Stocks SmithOnStocks Logo A.P. Pharma: Management Change is a Positive for the Stock (APPA.OB, $0.39) The Board of Directors of A.P. Pharma (APPA.OB) has brought in the management team that was responsible for founding the biotechnology company Ardea in 2006 and selling it to Astra Zeneca in April 2012 for $1.3 billion. Robert Rosen, who joined A.P. Pharma in October 2012 as Chief Commercial Officer, will be promoted to the role of President. On the third and final point, A.P. Pharma was unlucky as after submitted its NDA, there was a change in definition in what constituted moderate emetogenic chemotherapy or MEC and what constituted highly emetogenic chemotherapy or HEC. This was a great decision in that A.P. Pharma will probably not be forced to do a new financing at current depressed prices. My analysis suggests that the Company will have about $30 million at the end of 2013. I think that the Company will probably need to raise capital after the approval of APF 530, although perhaps not immediately. I would also point out that new management chose to sell Ardea before it commercialized its lead drug lesinurad and there is a possibility that A.P. Pharma could be sold prior to commercialization of APF 530. A.P. Pharma. APF530 (4)


Heron Therapeutics . A Specialty Pharmaceutical Company • Investor Relations • News Release

phx.corporate-ir.net [cached]

A.P. Pharma Appoints New Management Team
A.P. Pharma Each executive joined A.P. Pharma's A.P. Pharma A.P. Pharma A.P. Pharma A.P. Pharma's A.P. Pharma A.P. Pharma


smithonstocks.com

A.P. Pharma: Management Change is a Positive for the Stock (APPA.OB, $0.39)
A.P. Pharma: Management Change is a Positive for the Stock (APPA.OB, $0.39) | Expert Financial Analysis and Reporting | Smith on Stocks SmithOnStocks Logo A.P. Pharma: Management Change is a Positive for the Stock (APPA.OB, $0.39) The Board of Directors of A.P. Pharma (APPA.OB) has brought in the management team that was responsible for founding the biotechnology company Ardea in 2006 and selling it to Astra Zeneca in April 2012 for $1.3 billion. Robert Rosen, who joined A.P. Pharma in October 2012 as Chief Commercial Officer, will be promoted to the role of President. On the third and final point, A.P. Pharma was unlucky as after submitted its NDA, there was a change in definition in what constituted moderate emetogenic chemotherapy or MEC and what constituted highly emetogenic chemotherapy or HEC. This was a great decision in that A.P. Pharma will probably not be forced to do a new financing at current depressed prices. My analysis suggests that the Company will have about $30 million at the end of 2013. I think that the Company will probably need to raise capital after the approval of APF 530, although perhaps not immediately. I would also point out that new management chose to sell Ardea before it commercialized its lead drug lesinurad and there is a possibility that A.P. Pharma could be sold prior to commercialization of APF 530. A.P. Pharma: PDUFA Date on APF530 Looms and I Am a Buyer (APPA.OB, $0.70) Recently Added Board Member Brings Great Expertise to the Potential Launch of APF530 (APPA, $0.64) A.P. Pharma: Ondansetron's Link to QT Interval Prolongation is a Huge Positive for APF530 (APPA, $0.68) A.P. Pharma: Initiating Coverage with a Buy (APPA.OB, $0.42) Related Company Blogs Initiating Coverage of A.P. Pharma with a Buy (APPA, $0.42)


phx.corporate-ir.net

A.P. Pharma


phx.corporate-ir.net

A.P. Pharma Appoints New Management Team
A.P. Pharma Each executive joined A.P. Pharma's A.P. Pharma A.P. Pharma A.P. Pharma A.P. Pharma's A.P. Pharma A.P. Pharma


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory